Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/25/2026

Methylprednisolone Acetate for Intra‑Articular Injections: Evidence‑Based Recommendations

Indications for Use

  • The knee is the joint most frequently injected with intra‑articular methylprednisolone for osteoarthritis and inflammatory arthritis, reflecting its prevalence in clinical practice. 1
  • Acute flares of knee pain, particularly when accompanied by joint effusion, are a primary indication for a single intra‑articular methylprednisolone injection. 1
  • Acute gouty arthritis involving one or two large joints (e.g., knee, ankle) can be managed with intra‑articular methylprednisolone. 6
  • Inflammatory arthritis of grade 1 affecting two or fewer joints, unresponsive to NSAIDs and low‑dose oral prednisone, is an appropriate scenario for intra‑articular methylprednisolone therapy. 3

Efficacy and Duration of Benefit

  • A 40 mg intra‑articular methylprednisolone dose in the knee yields short‑term pain relief lasting 1–4 weeks; this benefit is supported by randomized evidence. 1
  • Across knee osteoarthritis trials, intra‑articular corticosteroids produce a mean effect size of 1.27 for pain reduction versus placebo, confirming clinically meaningful short‑term efficacy. 4
  • The therapeutic effect diminishes by 12–24 weeks, indicating that intra‑articular methylprednisolone is best reserved for acute symptom flares rather than long‑term disease control. 2

Injection Technique

  • Ultrasound guidance improves the accuracy of intra‑articular needle placement, reducing the risk of treatment failure due to extra‑articular injection. 5

Safety Precautions

  • Injections should only be performed after a definitive diagnosis is established and all contraindications (e.g., infection, coagulopathy) are excluded. 5
  • Patients with diabetes should monitor blood glucose for the first three days after injection, as transient hyperglycemia is common. 5

Re‑Injection Considerations

  • The decision to repeat an intra‑articular methylprednisolone injection should be individualized, weighing the magnitude and duration of prior benefit against potential risks. 5
  • Patients should avoid excessive use of the injected joint for at least 24 hours post‑procedure, but routine immobilization is not recommended. 5